Bioscience Bulletin
Bioscience Bulletin – Nov 14, 2025
On Monday, G2G Founder & CEO, Liz Powell was among the women’s health leaders at the Department of Health & Human Services (HHS) where Secretary Kennedy and FDA Director Marty Makary, announced that hormone replacement therapy (HRT) products for perimenopause and menopause would no longer need to carry black box warnings.
Read MoreBioscience Bulletin – Nov 9, 2025
Last week was an active week for health policy! Our Founder and CEO, Liz Powell, Esq., MPH attended the Milken Institute Future of Health Summit, in Washington, D.C.. She participated in the
Read MoreBioscience Bulletin
The shutdown that began on October 1 continues with no end in sight. Most Congressional Democrats refuse to support a bill to re-open the government without an extension of the Affordable Care Act subsidies, which is supported by 78% of the public according to polling by KFF.
Read More